Quantum-Si incorporated (QSI)
| Market Cap | 280.60M |
| Revenue (ttm) | 459,000 |
| Net Income (ttm) | -114.04M |
| Shares Out | 141.72M |
| EPS (ttm) | -0.82 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 681,060 |
| Open | 1.99 |
| Previous Close | 1.98 |
| Day's Range | 1.95 - 2.04 |
| 52-Week Range | 1.36 - 3.90 |
| Beta | 2.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2023 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of protein detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Carbon automated sample preparation instrument; the Platinum single-molecule detection and NGPS instrument with Time-Domain Sequencing chip; the Quantum-Si Cloud data analysis software; and reagent kits for use with its instruments. The company was founded in 2013 is based in Guilford, Connecticut. [Read more]
Financial Performance
Financial StatementsNews
Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors.
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Reports Second Quarter 2023 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Second Quarter 2023 Financial Results.
Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference.
Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023.
Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations.
Quantum-Si Debuts New Headquarters in Branford, Connecticut
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Debuts New Headquarters in Branford, Connecticut.
Quantum-Si to Participate in the Jefferies Healthcare Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Jefferies Healthcare Conference.
Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors.
Scott Mendel Elected to Quantum-Si Board of Directors
GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Scott Mendel Elected to Quantum-Si Board of Directors.
Quantum-Si Reports First Quarter 2023 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports First Quarter 2023 Financial Results.
Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer
GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Quantum-Si today announced the appointment of Jeff Keyes as its new Chief Financial Officer.
Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments
GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Quantum-Si bolsters executive leadership team with four key appointments.
Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results ...
Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023
GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will ...
Quantum-Si Reports Fourth Quarter and Fiscal Year 2022 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--March 6, 2023--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for th...
Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the 4...
Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
GUILFORD, Conn.
Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that management will discuss the foll...
Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ Next-Generation Protein Sequence Platform Output
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership an...
Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership wi...
Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Dec. 22, 2022--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be partic...
Quantum-Si Announces Commercial Availability of PlatinumTM, the World's First Next-Generation Single-Molecule Protein Sequencing Platform
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the commercial availability of Platin...
Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it has joined the Human Proteome Orga...